FACTORS ASSOCIATED WITH AND IMPLICATIONS OF MEETING OR NOT MEETING HBA1C TARGETS IN TYPE 2 DIABETES MELLITUS

Author(s)

Higgins V, Harrison L, Sullivan E, Piercy J
Adelphi Real World, Bollington, UK

OBJECTIVES : To compare patient characteristics, resource use and involvement in patients achieving/not achieving physician set HbA1c targets.

METHODS : Data were drawn from 2018 Adelphi Disease Specific Programme, a real-world, cross-sectional study in 5EU/USA. Physicians completed forms for the next 10 T2DM patients capturing demographics, clinical characteristics, disease duration, HbA1c targets, comorbidities, patient knowledge/involvement in their condition, resource use. Patients were classified into one of the following groups: Unmet target [1] HbA1c <7.5%, [2] HbA1c >7.5%, met target [3] HbA1c <7.5%, [4] HbA1c >7.5%.

RESULTS : Of 7372 patients included in the analysis, 6968 had HbA1c target <=7.5%; 46.3% currently achieving this with 403 having target >7.5% (41.3% achievement). Top reasons driving targets >7.5%: age (46%), non-compliance (33%), low patient engagement (31%), risk of hypoglycemia (26%) and weight concerns (19%). Patients unsuccessful at meeting goal ([1]/[2]) versus those successful ([3]/[4]) are more likely to be younger (59.4/63.5 vs. 61.8/69.6 [years]), working full-time (50/26% vs. 44/22%), have more comorbidities (2.8/4.4 vs. 2.6/4.1), high/very high cardiovascular risk (27/50% vs. 22/39%), total number of prescribed products (4.8/7.2 vs. 4.5/6.3 [per day]) and diabetologist visits (1.3/1.4 vs. 1.0/0.9 [per annum]). Unsuccessful patients are also more likely to have faster than average speed of disease progression (17/43% vs. 6/11%), have no knowledge (21/37% vs. 15/26%) or no involvement (26/46% vs. 22/30%) about treatment options. All results p<0.05

CONCLUSIONS : Whilst clinical guidelines advocate stringent HbA1c targets around 7.5%, it is recognized this differs in a real-world setting due to patient factors like age, risk of hypoglycemia and weight concerns. T2DMs not meeting goal not only contribute to healthcare system burden but are of working age. Given their lack of engagement, to help patients meet targets, physicians should place a greater emphasis on patient education and empowerment to promote more patient responsibility for their own health.

Conference/Value in Health Info

2019-05, ISPOR 2019, New Orleans, LA, USA

Value in Health, Volume 22, Issue S1 (2019 May)

Code

PDB9

Topic

Clinical Outcomes, Economic Evaluation

Topic Subcategory

Clinical Outcomes Assessment, Cost/Cost of Illness/Resource Use Studies

Disease

Diabetes/Endocrine/Metabolic Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×